Print this page    •   Back to Web version of article

IPS Reports on Harm Reduction Efforts to Slow Spread of HIV, Other Diseases in Afghanistan

April 6, 2011

Inter Press Service reports on efforts to slow the spread of HIV/AIDS and other diseases among Afghanistan's injection drug users through a drug substitution program. "The programme, which gives patients controlled doses of methadone to help them control their heroin addiction," is the country's "first major methadone drug substitution trial," according to the news service. The article notes the positive results of the trial to date, which are being presented at the International Harm Reduction Association's annual conference in the Lebanese capital Beirut this week. IPS writes that though "[d]octors on the programme ... say its results show the benefit harm reduction treatment can have in tackling the spread of blood-borne diseases among injecting drug users and help often-ostracised addicts reintegrate into society" and "[t]he Afghan health ministry has backed the methadone trial ... there are concerns over its future" (Stracansky, 4/5).

Back to other news for April 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art61373.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.